Join Date: Jul 2010
Location: Boston, MA
Mentioned: 0 Post(s)
Tagged: 0 Thread(s)
Quoted: 0 Post(s)
Surviving sleep deprivation one day at a time with dd (Oct '11) & ds (Oct '08).
Everyone has their own journeys & has to weigh things at different points. Do the drugs I'm taking worry me - yep. But we decided the risk was worth it as the alternative in our situation was no children of our own.
I'm grateful I had the option as I'm not sure how I ever would have gotten over the bitterness & intense sadness that clouded every day in the couple years before I conceived ds. It honestly overtook my entire life & still hurts to think about.
Hi - am I the only person to have concerns about the possible side effects of using infertility drugs on the health of the baby and/or cancer scares for want to be Moms?
I feel as though my desire to have my own children is heavily out weighed by this sense that I'm risking so much more. Am I alone in thinking this? I've read so many posts on this forum of courageous women battling through IVF, perhaps I'm not there yet in taking that leap into the unknown.
How does anyone reach that decision?
2. The baby has a higher risk for defects and autism. I understand that it is less from the meds themselves and more from the lack of natural selection - poor quality embryos ultimately develop. The other opinion is that the first stages of embryo development it the dish harm healthy development some how. Still, it is all statistics, having a higher risk does not mean it will happen. My DD fits into their statistics since she was an IVF baby and we had a high risk pg, c-section and low birth weight. Other than weight, she is fine.
Go with your heart.
|THE RISK OF CANCER IN IVF PATIENTS TREATED AT AGE 40 AND ABOVE
Tsafrir A., Lerner-Geva L., Eldar-Geva T., Barchana M. , Margalioth EJ., Simon A., Laufer N.
IVF Unit, Shaare-Zedek Medical Center, Jerusalem. IVF Unit, Hadassah Hebrew University Medical Center, Ein Kerem, Jerusalem, Woman and Children's Health Research Unit, Gertner Institute for Epidemiology and Health Policy Research, Tel Hashomer, Israel National Cancer Registry, Ministry of Health, and School of Public Health, Haifa University.
Introduction: Data regarding a possible association between fertility reatments and an increased risk for malignancy is conflicting. Current lnowledge is based mainly on the study of entire populations undergoing fertility treatments. These are usually women in their third and fourth decade of life. Women treated at an older age may be at higher risk because of longer
years of infertility and possibly exposure to numerous fertility treatments
Aim: To evaluate the risk of cancer in In Vitro Fertilisation (IVF) patients reated at age 40 and above.
Materials: The study population included all IVF patients aged 40 and older at two university affiliated IVF units in Jerusalem, Israel, during the period 1994-2004. The computerized data base was cross-linked with the Israel National Cancer Registry updated to 31.12.2006. The Standardized Incidence Ratios (SIR) and 95% confidence intervals were computed by comparing the observed cases to the expected cancer cases in the general Israeli population adjusted for gender and age. Patients' files were also reviewed to confirm the diagnosis of cancer and acquire further information
Results: 582 patients were included in the cohort. Mean age at first IVF cycle in the unit was 42±1.9. The mean follow up period was 7.5±2.5 years (range 2-11 years). 420 women (72% of all) were followed for 5 years and more. A total of 19 cases of cancer were diagnosed in the cohort as compared to 19.7 expected cases in the age-matched general Israeli population (standardized incidence ratios (SIR) = 0.96; 95% CI 0.58-1.51). Among those, 9 women were diagnosed with breast cancer, as compared to 9.37 expected (SIR=0.96; 95%CI 0.44-1.82). Three women had astrointestinal tumors, Two had hematological malignancies, one had uterine cancer and 3 had grade III cervical intraepithelial neoplasia
[B]Conclusions: In our cohort, IVF treatment of older women was not associated with an excess risk of cancer as compared with the general population[/B